IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

HHGHA Orlent; Rob de Knegt; HLA Janssen

doi:10.1016/j.jhep.2011.08.012

IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

HHGHA Orlent
, Rob de Knegt
, HLA Janssen

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	741-742
Number of pages	2
Journal	Journal of Hepatology
Volume	56
Issue number	3
DOIs	https://doi.org/10.1016/j.jhep.2011.08.012
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-04-20-02-A

Access to Document

10.1016/j.jhep.2011.08.012

http://hdl.handle.net/1765/37875

Cite this

@article{e49004cd29df4f57badf5264351a5c8f,

title = "IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?",

author = "HHGHA Orlent and \{de Knegt\}, Rob and HLA Janssen",

year = "2012",

doi = "10.1016/j.jhep.2011.08.012",

language = "Undefined/Unknown",

volume = "56",

pages = "741--742",

journal = "Journal of Hepatology",

issn = "0168-8278",